Exchange: NASDAQ·Updated 07:30 PM EDT

SRTA News

News
all
press releases
Strata Critical Medical, Inc. (SRTA) Upgraded to Buy: What Does It Mean for the Stock?
Strata Critical Medical, Inc. (SRTA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
More News
Does Strata Critical Medical, Inc. (SRTA) Have the Potential to Rally 47.28% as Wall Street Analysts Expect?
The mean of analysts' price targets for Strata Critical Medical, Inc. (SRTA) points to a 47.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks
Strata Critical Medical (SRTA) Q2 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
Immersion Investment Views Strata Critical Medical (SRTA) as a "Babushka Doll"
Immersion Investment Views Strata Critical Medical (SRTA) as a "Babushka Doll...
Yahoo! Finance: News
Can Strata Critical Medical, Inc. (SRTA) Run Higher on Rising Earnings Estimates?
Strata Critical Medical, Inc. (SRTA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks
Wall Street Analysts Predict a 60% Upside in Strata Critical Medical, Inc. (SRTA): Here's What You Should Know
The consensus price target hints at a 60% upside potential for Strata Critical Medical, Inc. (SRTA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks
Strata Critical Medical, Inc. (SRTA) Surges 8.5%: Is This an Indication of Further Gains?
Strata Critical Medical, Inc. (SRTA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
Strata Critical Medical Q1 2026 Earnings Call: Complete Transcript
read more...
Benzinga
Cathie Wood's Ark keeps selling one stock once again
Cathie Wood, head of Ark Investment Management, is known for making bold, conviction-driven bets, but she's just as quick to trim positions when the strategy shifts. That pattern is playing out again...
TheStreet.com
Strata Critical Medical (NASDAQ:SRTA) Upgraded to Hold at Zacks Research
Zacks Research raised Strata Critical Medical to a "hold" rating in a research report on Thursday...
MarketBeat

Advertisement|Remove ads.